Monomolecular G-quadruplex Structures with Inversion of Polarity Sites: New Topologies and Potentiality
Overview
Authors
Affiliations
In this paper, we report investigations, based on circular dichroism, nuclear magnetic resonance spectroscopy and electrophoresis methods, on three oligonucleotide sequences, each containing one 3'-3' and two 5'-5' inversion of polarity sites, and four G-runs with a variable number of residues, namely two, three and four (mTG2T, mTG3T and mTG4T with sequence 3'-TGnT-5'-5'-TGnT-3'-3'-TGnT-5'-5'-TGnT-3' in which n = 2, 3 and 4, respectively), in comparison with their canonical counterparts (TGnT)4 (n = 2, 3 and 4). Oligonucleotides mTG3T and mTG4T have been proven to form very stable unprecedented monomolecular parallel G-quadruplex structures, characterized by three side loops containing the inversion of polarity sites. Both G-quadruplexes have shown an all-syn G-tetrad, while the other guanosines adopt anti glycosidic conformations. All oligonucleotides investigated have shown a noteworthy antiproliferative activity against lung cancer cell line Calu 6 and colorectal cancer cell line HCT-116 p53-/-. Interestingly, mTG3T and mTG4T have proven to be mostly resistant to nucleases in a fetal bovine serum assay. The whole of the data suggest the involvement of specific pathways and targets for the biological activity.
Kotkowiak W, Roxo C, Pasternak A ACS Med Chem Lett. 2023; 14(1):35-40.
PMID: 36655120 PMC: 9841586. DOI: 10.1021/acsmedchemlett.2c00361.
Legatova V, Samoylenkova N, Arutyunyan A, Tashlitsky V, Zavyalova E, Usachev D Int J Mol Sci. 2021; 22(7).
PMID: 33806042 PMC: 8036578. DOI: 10.3390/ijms22073372.
Gangemi C, Alaimo S, Pulvirenti A, Garcia-Vinuales S, Milardi D, Falanga A Sci Rep. 2020; 10(1):453.
PMID: 31949213 PMC: 6965629. DOI: 10.1038/s41598-019-57289-8.
Therapeutic Approaches Targeting Nucleolus in Cancer.
Carotenuto P, Pecoraro A, Palma G, Russo G, Russo A Cells. 2019; 8(9).
PMID: 31527430 PMC: 6770360. DOI: 10.3390/cells8091090.
Sagi J J Nucleic Acids. 2017; 2017:1641845.
PMID: 29181193 PMC: 5664352. DOI: 10.1155/2017/1641845.